Table 1.
Baseline characteristics.
| Characteristics | Mean ± SD or N = 120, (%) |
|---|---|
| Age at diagnosis, years | 57.5 ± 8.2 |
| Gender | |
| Male | 89 (74.2) |
| Female | 31 (25.8) |
| Race | |
| White | 100 (83.3) |
| Black | 6 (5.0) |
| Asian | 8 (6.7) |
| Other | 6 (5.0) |
| Ethnicity | |
| Hispanic | 5 (4.2) |
| Non-Hispanic | 115 (95.8) |
| Etiology | |
| HCV | 70 (58.3) |
| Alcohol | 15 (12.5) |
| NAFLD | 11 (9.2) |
| HBV | 5 (4.2) |
| Alpha 1 anti-trypsin deficiency | 4 (3.3) |
| Autoimmune conditions (∗) | 10 (8.3) |
| Cryptogenic | 5 (4.2) |
| Mean number of HCCs | 1.5 ± 0.8 |
| Mean number of segments affected by HCC | 1.8 ± 0.9 |
| Segments | |
| Single segment involved | 60 (50.0) |
| Multi segments | 60 (50.0) |
| Single lesion | 81 (67.5) |
| Multifocal lesions | 39 (32.5) |
| Single lesion/single segment | 48 (59.3) |
| Single lesion/multi segments | 33 (40.7) |
| Segment 1 | 1 (0.8) |
| Segment 2 | 17 (14.2) |
| Segment 3 | 19 (15.8) |
| Segment 4a | 19 (15.8) |
| Segment 4b | 14 (11.7) |
| Segment 5 | 29 (24.2) |
| Segment 6 | 39 (32.5) |
| Segment 7 | 42 (35.0) |
| Segment 8 | 43 (35.8) |
| HCC size, cm | 3.1 ± 1.8 |
| AFP | 156.0 ± 507.4 |
| Survival time, months | 80.5 ± 40.7 |
| Microvascular invasion | 28 (23.3) |
| Recurrence | 14 (14.0) |
(∗) Autoimmune conditions: autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis. HCC: hepatocellular carcinoma; AFP: alpha fetoprotein; HCV: hepatitis C virus; HBV: hepatitis B virus; NAFLD: nonalcoholic fatty liver disease; SD: standard deviation; N: number of cases.